NCT06912100View on ClinicalTrials.gov

L. Acidophilus (Strain TW01) on Gut Health, Body Composition, and Inflammation

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Overweight (BMI > 25)Obese, Otherwise Healthy Volunteers
Interventions
DIETARY_SUPPLEMENT

Placebo

Participants consume capsules containing only an inactive placebo (maltodextrin and magnesium stearate).

DIETARY_SUPPLEMENT

Probiotic

Participants consume capsules containing L. acidophilus (TW01) at 4×10\^10 CFU/capsule (three capsules daily, totaling 1.2×10\^11 CFU/day) plus a commercial fiber source (Fibersol-2).

Trial Locations (1)

06269

RECRUITING

University of Connecticut, Department of Nutritional Sciences, Storrs

All Listed Sponsors
lead

University of Connecticut

OTHER